Vanguard Fiduciary Trust
CNSY

Vanguard Fiduciary Trust’s Cerenome CNSY Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Sell
36,868
-9,683
-21% -$52.8K ﹤0.01% 3637
2026
Q1 		$190K Buy
+46,551
New +$353K ﹤0.01% 3534

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Vanguard Fiduciary Trust's CNSY Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Cerenome (CNSY) stake by 21% in Q2 2026, selling an estimated $52.8K and leaving 36,868 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

Vanguard Fiduciary Trust first reported a position in CNSY in Q1 2026 and has held it in 2 quarters since. The position peaked at $190K in Q1 2026. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Vanguard Fiduciary Trust held 36,868 shares of Cerenome worth $161K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 9,683 Cerenome shares in Q2 2026, an estimated $52.8K.
  • Cerenome made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3637 holding.
  • Vanguard Fiduciary Trust first reported a position in Cerenome in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Cerenome position peaked at $190K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.